Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer.

ABSTRACT:

SUBMITTER: Vlaeminck-Guillem V 

PROVIDER: S-EPMC7807368 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature